Victoza (Liraglutide) FDA-approved for: Type 2 diabetes in adults and children (ages 10+) Dosing: Once-daily injection, any time of day Device: Multi-dose pre-filled pen Victoza reduces MACE risk in patients with heart disease
Appetite suppression often arrives before weight loss, gastrointestinal effects peak after escalation, and both soften as the dose settles
The science is still developing and it's a space worth watching rather than packing over
PMC 1703637
While GHK-Cu focuses on stimulating collagen production, GHK Basic mainly emphasizes cellular repair and anti-inflammatory effects
doi: 10.2337/dc10-1006 [DOI] [PMC free article] [PubMed] [Google Scholar] 17.Lagman M, Ly J, Saing T, Kaur Singh M, Vera Tudela E, Morris D, et al